Safety of meloxicam: a global analysis of clinical trials [British Journal of Rheumatology, 1996;35(suppl. 1):68-77].
Fenn
G C
GC
Morant
S V
SV
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D000077239:Meloxicam; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013843:Thiazines / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D013844:Thiazoles / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D013843:Thiazines; D013844:Thiazoles; D000077239:Meloxicam